Georg Stuessi

Institute of Oncology Research

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Davide Rossi

Institute of Oncology Research

Rudolf Benz

Kantonsspital Münsterlingen

Nicolas Bonadies

University of Bern

Emanuele Zucca

Institute of Oncology Research

Jakob Passweg

University Hospital of Basel

Markus G. Manz

University Hospital of Zurich

Alicia Rovó

University Hospital of Bern

Mario Bargetzi

Kantonsspital Aarau

B. Gerber

Institute of Oncology Research

Gianluca Gaïdano

Università degli Studi del Piemonte Orientale “Amedeo Avogadro”

Cooperative Institutions

Institute of Oncology Research

Università della Svizzera italiana

University of Bern

University Hospital of Bern

Erasmus MC

University Hospital of Basel

University of Basel

Istituti di Ricovero e Cura a Carattere Scientifico

Ente Ospedaliero Cantonale

Palmetto Hematology Oncology

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Leukemia (2020)

GJ Ossenkoppele DA Breems Georg Stuessi Yvette van Norden Mario Bargetzi

10.1038/s41375-020-0994-7

Cite

Citations (0)

A Prognostic Tool for the Identification of Patients with Early Stage Chronic Lymphocytic Leukemia at Risk of Progression

Blood (2018)

Adalgisa Condoluci Lodovico Terzi di Bergamo Lorenzo De Paoli Julio Delgado Massimo Gentile

Nomogram

Tolerability

10.1182/blood-2018-99-116325

Cite

Citations (2)

Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012

Cancer Epidemiology (2017)

Nicolas Bonadies Anita Feller Alicia Rovó Axel Ruefer Sabine Blum

Relative survival

10.1016/j.canep.2016.12.005

Cite

Citations (30)

HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia (2022)

Lodovico Terzi di Bergamo Maria Cristina Pirosa Alessio Bruscaggin Matin Salehi Valeria Spina

10.1016/s2152-2650(22)01480-x

Cite

Citations (0)

Secreted Factors Determine Resistance to Idelalisib in Marginal Zone Lymphoma Models of Resistance

Blood (2019)

Alberto J. Arribas Sara Napoli Eugenio Gaudio Luciano Cascione Alessandra Di Veroli

Idelalisib

10.1182/blood-2019-124299

Cite

Citations (5)

Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2-Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14

Blood (2016)

Beatrice Drexler Jakob Passweg Martin Bigler Alexandre Theocharides Nathan Cantoni

10.1182/blood.v128.22.3108.3108

Cite

Citations (6)

Trends of Classification, Incidence, Mortality, and Survival of MDS Patients in Switzerland Between 2001 and 2012

Blood (2016)

Nicolas Bonadies Anita Feller Alicia Rovó Axel Ruefer Sabine Blum

10.1182/blood.v128.22.5539.5539

Cite

Citations (0)

Poster: HL-370 Fragmentome Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma

Clinical Lymphoma Myeloma & Leukemia (2022)

Lodovico Terzi di Bergamo Maria Cristina Pirosa Alessio Bruscaggin Matin Salehi Valeria Spina

Profiling (computer programming)

Classical Hodgkin lymphoma

10.1016/s2152-2650(22)00995-8

Cite

Citations (0)

Improvement of Relative Survival in Elderly Patients with Acute Myeloid Leukemia Emerging from Population-Based Cancer Registries in Switzerland from 2001-2013

Blood (2017)

Annatina Schnegg‐Kaufmann Anita Feller Helen Boldomero Alicia Rovó Markus G. Manz

Relative survival

10.1182/blood.v130.suppl_1.863.863

Cite

Citations (0)

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Leukemia (2020)

GJ Ossenkoppele Dimitri Breems Georg Stuessi Yvette van Norden Mario Bargetzi

10.1038/s41375-020-0725-0

Cite

Citations (20)